Vyome Holdings, Inc.
Biotechnology • Healthcare • Cambridge, MA, United States • HIND (NCM)
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Stock Performance (90 Days)
Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).
Layoff History
No layoff events recorded for this company.
Recent News
Vyome To Begin Trading On Nasdaq Via Reverse Merger With ReShape Lifesciences Tomorrow - Nasdaq
Nasdaq • Aug 14
Vyome to begin trading as Vyome Holdings under HIND symbol - Investing.com
Investing.com • Aug 14
HIND Stock: Growth or Bubble? - StocksToTrade
StocksToTrade • Sep 17
Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity - Yahoo Finance
Yahoo Finance • Sep 17
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell - Business Wire
Business Wire • Aug 15
Other Biotechnology Companies
View All →
Frequently Asked Questions
Has Vyome Holdings, Inc had layoffs?
No layoff events have been recorded for Vyome Holdings, Inc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Vyome Holdings, Inc have?
Vyome Holdings, Inc has approximately 17 employees.
What industry is Vyome Holdings, Inc in?
Vyome Holdings, Inc operates in the Biotechnology industry, within the Healthcare sector.
Is Vyome Holdings, Inc a publicly traded company?
Yes, Vyome Holdings, Inc is publicly traded under the ticker symbol HIND on the NCM. The company has a market capitalization of approximately $0.02 billion.
Where is Vyome Holdings, Inc headquartered?
Vyome Holdings, Inc is headquartered in Cambridge, MA, United States at Harvard Square, Cambridge, MA 02138, United States.
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.